831 related articles for article (PubMed ID: 12809846)
1. Transarterial chemoembolization for inoperable, early stage hepatocellular carcinoma in patients with Child-Pugh grade A and B: results of a comparative study in 96 Chinese patients.
Yuen MF; Chan AO; Wong BC; Hui CK; Ooi GC; Tso WK; Yuan HJ; Wong DK; Lai CL
Am J Gastroenterol; 2003 May; 98(5):1181-5. PubMed ID: 12809846
[TBL] [Abstract][Full Text] [Related]
2. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.
Takayasu K; Arii S; Ikai I; Omata M; Okita K; Ichida T; Matsuyama Y; Nakanuma Y; Kojiro M; Makuuchi M; Yamaoka Y;
Gastroenterology; 2006 Aug; 131(2):461-9. PubMed ID: 16890600
[TBL] [Abstract][Full Text] [Related]
3. Combination therapy with transarterial chemoembolization and interferon-alpha compared with transarterial chemoembolization alone for hepatitis B virus related unresectable hepatocellular carcinoma.
Li M; Lu C; Cheng J; Zhang J; Cao C; Xu J; Xu J; Pan H; Zhong B; Tucker S; Wang D
J Gastroenterol Hepatol; 2009 Aug; 24(8):1437-44. PubMed ID: 19486255
[TBL] [Abstract][Full Text] [Related]
4. A randomized controlled trial of transcatheter arterial chemoembolization with lipiodol, doxorubicin and cisplatin versus intravenous doxorubicin for patients with unresectable hepatocellular carcinoma.
Mabed M; Esmaeel M; El-Khodary T; Awad M; Amer T
Eur J Cancer Care (Engl); 2009 Sep; 18(5):492-9. PubMed ID: 19453695
[TBL] [Abstract][Full Text] [Related]
5. Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion.
Kim KM; Kim JH; Park IS; Ko GY; Yoon HK; Sung KB; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
J Gastroenterol Hepatol; 2009 May; 24(5):806-14. PubMed ID: 19207681
[TBL] [Abstract][Full Text] [Related]
6. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.
Marelli L; Shusang V; Buscombe JR; Cholongitas E; Stigliano R; Davies N; Tibballs J; Patch D; Meyer T; Burroughs AK
J Nucl Med; 2009 Jun; 50(6):871-7. PubMed ID: 19443599
[TBL] [Abstract][Full Text] [Related]
7. [High intensity focused ultrasound therapy combined with transcatheter arterial chemoembolization for advanced hepatocellular carcinoma].
Jin CB; Wu F; Wang ZB; Chen WZ; Zhu H
Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):401-3. PubMed ID: 12921577
[TBL] [Abstract][Full Text] [Related]
8. Complete necrosis after transarterial chemoembolization could predict prolonged survival in patients with recurrent intrahepatic hepatocellular carcinoma after curative resection.
Shim JH; Kim KM; Lee YJ; Ko GY; Yoon HK; Sung KB; Park KM; Lee SG; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
Ann Surg Oncol; 2010 Mar; 17(3):869-77. PubMed ID: 20033326
[TBL] [Abstract][Full Text] [Related]
9. Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: evaluation of two kinds of dosages of anticancer drugs and analysis of prognostic factors.
Lu W; Li Y; He X; Chen Y
Hepatogastroenterology; 2003; 50(54):2079-83. PubMed ID: 14696468
[TBL] [Abstract][Full Text] [Related]
10. Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma.
O'Suilleabhain CB; Poon RT; Yong JL; Ooi GC; Tso WK; Fan ST
Br J Surg; 2003 Mar; 90(3):325-31. PubMed ID: 12594668
[TBL] [Abstract][Full Text] [Related]
11. [A comparison of patients with hepatocellular carcinoma between a short-term (less than 6 months) survival group and a long-term (over 24 months) survival group after treatment with transcatheter arterial chemoembolization].
Kang IK; Kim SW; Hahn SH; Cho SC; Gham CW; Lee DH
Taehan Kan Hakhoe Chi; 2002 Jun; 8(2):189-200. PubMed ID: 12499805
[TBL] [Abstract][Full Text] [Related]
12. Preoperative chemoembolization in patients with hepatocellular carcinoma undergoing liver transplantation: influence of emergent versus elective procedures on patient survival and tumor recurrence rate.
Stockland AH; Walser EM; Paz-Fumagalli R; McKinney JM; May GR
Cardiovasc Intervent Radiol; 2007; 30(5):888-93. PubMed ID: 17619218
[TBL] [Abstract][Full Text] [Related]
13. [Influence of different treatment modalities on survival of patients with two -stage resection of unresectable hepatocellular carcinoma].
Fan J; Wu Z; Tang Z
Zhonghua Wai Ke Za Zhi; 2001 Oct; 39(10):745-8. PubMed ID: 16201184
[TBL] [Abstract][Full Text] [Related]
14. Chemoembolization in patients at high risk: results and complications.
Kiely JM; Rilling WS; Touzios JG; Hieb RA; Franco J; Saeian K; Quebbeman EJ; Pitt HA
J Vasc Interv Radiol; 2006 Jan; 17(1):47-53. PubMed ID: 16415132
[TBL] [Abstract][Full Text] [Related]
15. Comparison of MELD and Child-Pugh scores to predict survival after chemoembolization for hepatocellular carcinoma.
Brown DB; Fundakowski CE; Lisker-Melman M; Crippin JS; Pilgram TK; Chapman W; Darcy MD
J Vasc Interv Radiol; 2004 Nov; 15(11):1209-18. PubMed ID: 15525739
[TBL] [Abstract][Full Text] [Related]
16. A case-control study comparing percutaneous radiofrequency ablation alone or combined with transcatheter arterial chemoembolization for hepatocellular carcinoma.
Peng ZW; Chen MS; Liang HH; Gao HJ; Zhang YJ; Li JQ; Zhang YQ; Lau WY
Eur J Surg Oncol; 2010 Mar; 36(3):257-63. PubMed ID: 19643561
[TBL] [Abstract][Full Text] [Related]
17. Transcatheter arterial chemoembolization therapy using iodized oil for patients with unresectable hepatocellular carcinoma: evaluation of three kinds of regimens and analysis of prognostic factors.
Ueno K; Miyazono N; Inoue H; Nishida H; Kanetsuki I; Nakajo M
Cancer; 2000 Apr; 88(7):1574-81. PubMed ID: 10738215
[TBL] [Abstract][Full Text] [Related]
18. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
[TBL] [Abstract][Full Text] [Related]
19. Prognostic analysis of transarterial chemoembolization combined with a traditional Chinese herbal medicine formula for treatment of unresectable hepatocellular carcinoma.
Yu Y; Lang QB; Chen Z; Li B; Yu CQ; Zhu DZ; Huang XQ; Zhai XF; Ling CQ
Chin Med J (Engl); 2009 Sep; 122(17):1990-5. PubMed ID: 19781383
[TBL] [Abstract][Full Text] [Related]
20. Superselective transarterial chemoembolization vs hepatic resection for resectable early-stage hepatocellular carcinoma in patients with Child-Pugh class a liver function.
Hsu KF; Chu CH; Chan DC; Yu JC; Shih ML; Hsieh HF; Hsieh TY; Yu CY; Hsieh CB
Eur J Radiol; 2012 Mar; 81(3):466-71. PubMed ID: 21376495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
